Valuation: Vitrolife AB

Market Cap 12.14B 1.21B 1.08B 1.01B 915M 1.72B 117B 1.74B 4.72B 59.5B 4.54B 4.44B 192B P/E 2026 *
24.6x
P/E 2027 * 19.9x
Enterprise Value 12.69B 1.26B 1.13B 1.05B 957M 1.8B 122B 1.81B 4.94B 62.19B 4.75B 4.65B 201B EV / Sales 2026 *
3.67x
EV / Sales 2027 * 3.27x
Free-Float
54.39%
Yield 2026 *
1.23%
Yield 2027 * 1.41%
1 day-2.34%
1 week-3.81%
Current month-5.73%
1 month-5.63%
3 months-1.59%
6 months-3.34%
Current year-34.56%
1 week 89.65
Extreme 89.65
95.6
1 month 88.8
Extreme 88.8
95.65
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 2023-07-31
Director of Finance/CFO 55 2025-10-09
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 2013-04-18
Chairman 70 2023-07-31
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
2/6/26 Buy

Chief Operating Officer

6,470 0.0048%
2/6/26 Buy

Chief Executive Officer

3,013 0.0022%
2/4/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-2.34%-3.81%-34.61%-34.56% 1.24B
+2.67%-1.17%-25.63%+4.65% 169B
+1.84%-0.76%-9.96%+15.34% 110B
+3.55%+4.72%-23.02%+7.15% 106B
+1.19%+0.42%-48.90%-11.41% 73.87B
+1.90%+2.61%+4.02%+72.41% 58.98B
+1.32%+4.32%+14.41%+64.37% 51.28B
+2.19%-1.71%-6.68%-30.44% 48.16B
+1.67%+1.50%-16.50%+21.67% 40.84B
+1.80%+0.32%+29.60%-0.91% 32.21B
Average +1.58%-0.92%-11.73%+10.83% 69.14B
Weighted average by Cap. +2.21%-1.30%-15.30%+13.47%

Financials

2026 *2027 *
Net sales 3.46B 345M 307M 286M 261M 491M 33.19B 494M 1.34B 16.95B 1.29B 1.27B 54.82B 3.71B 369M 329M 307M 279M 527M 35.58B 530M 1.44B 18.17B 1.39B 1.36B 58.78B
Net income 493M 49.09M 43.73M 40.78M 37.13M 69.97M 4.73B 70.42M 192M 2.41B 184M 180M 7.81B 609M 60.67M 54.05M 50.4M 45.89M 86.49M 5.84B 87.04M 237M 2.98B 228M 223M 9.65B
Net Debt 549M 54.72M 48.75M 45.46M 41.39M 78.01M 5.27B 78.51M 214M 2.69B 205M 201M 8.71B -26.74M -2.66M -2.37M -2.21M -2.02M -3.8M -257M -3.82M -10.4M -131M -10.01M -9.79M -424M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
26-10-05 SEK 89.65 -2.34% 566,754
26-10-02 SEK 91.80 -1.13% 68,712
26-10-01 SEK 92.85 -2.37% 72,119
26-09-30 SEK 95.10 +3.15% 115,136
26-09-29 SEK 92.20 -0.32% 198,962
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
89.65SEK
Average target price
129.60SEK
Spread / Average Target
+44.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock